Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial
about
Antiplatelet resistance in strokeThe safety of clopidogrel.The impact of treatment with omeprazole on the effectiveness of clopidogrel drug therapy during the first year after successful coronary stentingStudy design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemEffects of drug interactions on biotransformation and antiplatelet effect of clopidogrel in vitro.Clinical importance of aspirin and clopidogrel resistanceConcomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation.Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention.Atorvastatin and statins in the treatment of heart failure.Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke.Interaction between cigarette smoking and clinical benefit of clopidogrel.Interaction between statins and clopidogrel: is there anything clinically relevant?Platelet P2Y12 receptor inhibition by thienopyridines: status and future.Clopidogrel before elective percutaneous coronary intervention.Prasugrel: a critical comparison with clopidogrel.Factors associated with clopidogrel nonresponsiveness.Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel: Evidences and Perspectives.Antiplatelet therapy in acute coronary syndromes.Review article: proton pump inhibitors with clopidogrel--evidence for and against a clinically-important interaction.Clinical value of antiplatelet therapy in patients with acute coronary syndromes and in percutaneous coronary intervention.Role of antiplatelet therapy in secondary prevention of acute coronary syndrome.A comprehensive comparative review of adenosine diphosphate receptor antagonists.InforMatrix: ADP antagonists in acute coronary syndromes.Simvastatin interactions with other drugs.Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives.CYP-mediated pharmacologic interference with optimal platelet inhibition.Monitoring aspirin and clopidogrel response: testing controversies and recommendations.Drug interactions with statins.Clinical implications of drug-drug interactions with P2Y12 receptor inhibitors.Drug-drug interaction with statins.Clinical relevance of clopidogrel-proton pump inhibitors interaction.Clopidogrel pathway.Antiplatelet resistance in outpatients with monitored adherence.[Platelet function: new drugs, new assays : possible impacts on operative medicine?].Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.Effect of atorvastatin on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy subjects.Epidemiology of CYP3A4-mediated clopidogrel drug-drug interactions and their clinical consequences.
P2860
Q22305927-C2167A34-9789-490A-844C-CA78595D3A11Q33392895-4E9056C0-8F4C-4C23-B695-644CDA65F7BCQ33776115-7263B6FF-7F32-41C0-9A9E-0594ED0D0803Q34114530-936C1218-6F0F-474D-9597-3C9AC0597A5EQ34339780-6DE1E66C-4924-4FC5-9E22-EC19DBFADFACQ34390050-1902CCA8-CE08-428B-8720-62F3BB247E21Q36088008-3480B924-B1AA-4D76-882C-3B9169F463CFQ36992366-E901B0E9-72FD-4CA9-BBA2-D0E1F42D4491Q37000767-642460AF-814B-46C0-8461-70BB84AC2C6BQ37067222-8DDBBB2D-0CCA-4788-B2F1-E33EA5AF1012Q37176153-288C2F3A-71C0-4FBC-89E2-0A1A5262C0FEQ37234094-611830A5-120F-43CF-95AF-D31689C0CA48Q37579228-07BB5A9E-90FD-4F32-89B4-4A5C0C9E3CEDQ37605466-29062A0E-5C9F-4DFB-A250-B57885084CB8Q37641320-D0E63C01-E36B-4498-8A16-80AEEE940FEAQ37709405-A389C11C-837F-48EC-BB9F-D00C72CDEA50Q37724614-0792254B-2140-4A1E-A779-ADEF40854DD9Q37798110-DDF36602-647D-4247-B4FE-4C6ACA624D5AQ37837981-9C6E061B-4424-4D8E-A2DC-E21A5843555DQ37841560-FA332C5D-6978-4B7C-A835-D388898BBB08Q37953259-2CE1F61D-B7ED-4714-8A76-2800A98161ABQ37973114-4BF13434-B2C9-465B-9EF8-54773277C0D9Q37973397-B88F5B6F-1B5D-4D40-92F5-4B5C76C7D6EAQ37993600-3D0B466F-48BC-482D-91AA-885E40317716Q38018679-F419D0D3-CD57-4872-A2EA-948BA87855E3Q38073672-3448EFD7-ACCB-4BA8-8CC8-3A57A3EE2AE8Q38099235-7011E732-A4F6-4EC0-AB31-1C41665D158EQ38155016-D1E0B5AC-75DD-4E29-BE7B-AE9AF174952AQ38177048-457DC26D-A0A8-4FDF-8F5D-B1A2F084E8DCQ38177333-BD762060-852E-4BB8-A83C-5664E5BDA52EQ38463745-2436B36B-061A-40DE-9AF7-74EFC284FFEEQ41829299-66A034F4-6822-4474-9D2E-2F5A75CE61B0Q43888035-500D9E16-1BC3-4AD4-A1DA-53C634311E47Q44621004-DA3D3F1A-9642-44BF-A0F5-053C3901A27FQ45956876-26A8BFB4-1BC5-412C-AA88-C1692369C5C4Q46234082-78F2105E-CAFC-4C84-9BE8-5B31991EDDA8Q46320953-44819696-9974-4DDB-B50F-BDD4B5D5CD82
P2860
Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial
@ast
Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial
@en
Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial
@nl
type
label
Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial
@ast
Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial
@en
Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial
@nl
prefLabel
Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial
@ast
Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial
@en
Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial
@nl
P2093
P50
P3181
P1476
Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial
@en
P2093
Jacqueline Saw
Koon-Hou Mak
P3181
P356
10.1016/J.JACC.2007.01.097
P407
P577
2007-07-24T00:00:00Z